Michelle Lunn Charity Golf Outing

MLHOPE Foundation

Leukemia, lymphoma (non and Hodgkins), myeloma and myelodysplastic syndromes are diseases that can affect the bone marrow, the blood cells, the lymph nodes and other parts of the lymphatic systems. An estimated combined total of 156,420 people in the US are expected to be diagnosed with leukemia, lymphoma or myeloma this year.

• Every 3 minutes someone is diagnosed with a blood cancer and every 10 minutes someone dies.

Leukemia
• Leukemia causes more deaths than any other cancer among children and young adults under the age of 20.

• In the US an estimated 327,520 people are living with, or are in remission from leukemia

• The relative five-year survival rate for patients with leukemia has nearly quadrupled in the last 49 years.

Lymphoma
• There are an estimated 761,659 people today living with lymphoma: 177,526 have or are in remission from Hodgkins lymphoma; 584,133 have or are in remission from non-Hodgkins lymphoma (NHL).

• The five-year relative survival rate for patients with Hodgkins lymphoma has more than doubled from 40 percent between 1960 and 1963, to almost 88 percent between 1999 and 2006.
• The five-year relative survival rate for NHL patients rose from 31 percent between 1960 and 1963, to just over 69 percent between 1999-2006.

Myeloma

• There are an estimated 95,874 people living with or in remission from myeloma in the US.
• This year 24,050 people are expected to be diagnosed with myeloma.

Our Mission: Our foundation was created in memory of Michelle Lunn who at the young age of 22.

Our foundation was created in memory of Michelle Lunn who at the young age of 22 died from (ALL) acute lymphoblastic leukemia. We established this non profit 501(c)(3) tax exempt foundation in Michelle’s name to try and make a difference in the lives of those suffering from blood cancer. We raise funds and to financially help those diagnosed with a blood cancer. We also raise money to fund research projects as well as award memorial scholarships in Michelle’ memory.